These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2554535)

  • 1. A possible cellular mechanism of cisplatin-induced nephrotoxicity.
    Singh G
    Toxicology; 1989 Sep; 58(1):71-80. PubMed ID: 2554535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity.
    Zsengellér ZK; Ellezian L; Brown D; Horváth B; Mukhopadhyay P; Kalyanaraman B; Parikh SM; Karumanchi SA; Stillman IE; Pacher P
    J Histochem Cytochem; 2012 Jul; 60(7):521-9. PubMed ID: 22511597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of Mitochondrial Damage and Mitophagy in Cisplatin-Mediated Nephrotoxicity.
    Ichinomiya M; Shimada A; Ohta N; Inouchi E; Ogihara K; Naya Y; Nagane M; Morita T; Satoh M
    Tohoku J Exp Med; 2018 Sep; 246(1):1-8. PubMed ID: 30175722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain.
    Kruidering M; Van de Water B; de Heer E; Mulder GJ; Nagelkerke JF
    J Pharmacol Exp Ther; 1997 Feb; 280(2):638-49. PubMed ID: 9023274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathological role of Bax in cisplatin nephrotoxicity.
    Wei Q; Dong G; Franklin J; Dong Z
    Kidney Int; 2007 Jul; 72(1):53-62. PubMed ID: 17410096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic study of cisplatin-induced nephrotoxicity.
    Portilla D; Li S; Nagothu KK; Megyesi J; Kaissling B; Schnackenberg L; Safirstein RL; Beger RD
    Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice.
    Kimura T; Nojiri T; Hosoda H; Ishikane S; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
    Cancer Chemother Pharmacol; 2015 May; 75(5):1057-63. PubMed ID: 25814217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin nephrotoxicity and protection by silibinin.
    Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
    Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panax notoginseng saponins attenuated cisplatin-induced nephrotoxicity.
    Liu SJ; Zhou SW
    Acta Pharmacol Sin; 2000 Mar; 21(3):257-60. PubMed ID: 11324427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of apoptosis and necroptosis inhibitors in cisplatin-induced nephrotoxicity.
    Tristão VR; Pessoa EA; Nakamichi R; Reis LA; Batista MC; Durão Junior Mde S; Monte JC
    Apoptosis; 2016 Jan; 21(1):51-9. PubMed ID: 26519037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of aldo-keto reductase (AKR7A1) and glutathione S-transferase pi (GSTP1) as novel renal damage biomarkers following exposure to mercury.
    Shin YJ; Kim KA; Kim ES; Kim JH; Kim HS; Ha M; Bae ON
    Hum Exp Toxicol; 2018 Oct; 37(10):1025-1036. PubMed ID: 29298499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanism of PNS protection against cisplatin-induced nephrotoxicity in rat models.
    Liu X; Huang Z; Zou X; Yang Y; Qiu Y; Wen Y
    Toxicol Mech Methods; 2015; 25(5):347-54. PubMed ID: 25598344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histochemical approach to the mechanism of action of cisplatin and its analogues.
    Aggarwal SK
    J Histochem Cytochem; 1993 Jul; 41(7):1053-73. PubMed ID: 8515048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK; Kwon YE
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria.
    Rodrigues MA; Rodrigues JL; Martins NM; Barbosa F; Curti C; Santos NA; Santos AC
    Chem Biol Interact; 2011 Jan; 189(1-2):45-51. PubMed ID: 21044617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture.
    Tay LK; Bregman CL; Masters BA; Williams PD
    Cancer Res; 1988 May; 48(9):2538-43. PubMed ID: 2965614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-type fatty acid binding protein transgenic mouse as a novel tool to explore cytotoxicity to renal proximal tubules.
    Nakamura K; Ito K; Kato Y; Sugaya T; Kubo Y; Tsuji A
    Drug Metab Pharmacokinet; 2008; 23(4):271-8. PubMed ID: 18762714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.